3D organ-on-a-chip: The convergence of microphysiological systems and organoids

Medicine today faces the combined challenge of an increasing number of untreatable diseases and fewer drugs reaching the clinic. While pharmaceutical companies have increased the number of drugs in early development and entering phase I of clinical trials, fewer actually successfully pass phase III...

Descripción completa

Detalles Bibliográficos
Autores principales: Baptista, Leandra S., Porrini, Constance, Kronemberger, Gabriela S., Kelly, Daniel J., Perrault, Cecile M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720174/
https://www.ncbi.nlm.nih.gov/pubmed/36478741
http://dx.doi.org/10.3389/fcell.2022.1043117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720174/
https://www.ncbi.nlm.nih.gov/pubmed/36478741
http://dx.doi.org/10.3389/fcell.2022.1043117

Ejemplares similares